DK1035203T3 - Cellekultur-tilpassede, genetisk manipulerede mutanter af infektiös bursalsyge-virus (IBDV) - Google Patents

Cellekultur-tilpassede, genetisk manipulerede mutanter af infektiös bursalsyge-virus (IBDV)

Info

Publication number
DK1035203T3
DK1035203T3 DK00200709T DK00200709T DK1035203T3 DK 1035203 T3 DK1035203 T3 DK 1035203T3 DK 00200709 T DK00200709 T DK 00200709T DK 00200709 T DK00200709 T DK 00200709T DK 1035203 T3 DK1035203 T3 DK 1035203T3
Authority
DK
Denmark
Prior art keywords
ibdv
cell culture
bursal disease
infectious bursal
genetically engineered
Prior art date
Application number
DK00200709T
Other languages
Danish (da)
English (en)
Inventor
Adriaan Antonius Wilhelmus Maria Loon
Egbert Mundt
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1035203T3 publication Critical patent/DK1035203T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00200709T 1999-03-05 2000-02-28 Cellekultur-tilpassede, genetisk manipulerede mutanter af infektiös bursalsyge-virus (IBDV) DK1035203T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200647 1999-03-05

Publications (1)

Publication Number Publication Date
DK1035203T3 true DK1035203T3 (da) 2004-08-30

Family

ID=8239949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00200709T DK1035203T3 (da) 1999-03-05 2000-02-28 Cellekultur-tilpassede, genetisk manipulerede mutanter af infektiös bursalsyge-virus (IBDV)

Country Status (14)

Country Link
US (2) US6492148B1 (de)
EP (1) EP1035203B1 (de)
JP (2) JP4675447B2 (de)
KR (1) KR100709077B1 (de)
AT (1) ATE266097T1 (de)
BR (1) BR0001011B1 (de)
CA (1) CA2298956C (de)
DE (1) DE60010358T2 (de)
DK (1) DK1035203T3 (de)
ES (1) ES2220333T3 (de)
HU (1) HU226254B1 (de)
PL (1) PL198981B1 (de)
PT (1) PT1035203E (de)
ZA (1) ZA200001069B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136232A0 (en) * 2000-05-18 2001-05-20 Bar Ilan University Res Author Measurements of enzymatic activity in a single, individual cell in population
CN1592794A (zh) * 2001-03-09 2005-03-09 加利福尼亚大学董事会 用于合成感染性丙型肝炎病毒的细胞培养系统
WO2003035824A1 (en) * 2001-10-25 2003-05-01 Bar-Ilan University Interactive transparent individual cells biochip processor
IL154677A0 (en) 2003-02-27 2003-09-17 Univ Bar Ilan A method and apparatus for manipulating an individual cell
US7888110B2 (en) 2003-06-26 2011-02-15 Seng Enterprises Ltd. Pico liter well holding device and method of making the same
EP1654347B1 (de) * 2003-06-26 2014-06-04 Seng Enterprises Limited Verbesserte Materialien zur Konstruktion von Zellchips, Zellchip-Abdeckungen, Zellchip-Hüllen, prozessierte Zellchips und Verwendungen davon
US9200245B2 (en) * 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
US8597597B2 (en) 2003-06-26 2013-12-03 Seng Enterprises Ltd. Picoliter well holding device and method of making the same
WO2005008626A1 (en) * 2003-07-11 2005-01-27 University Of North Carolina At Chapel Hill Methods and systems for controlling a computer using a video image and for combining the video image with a computer desktop
US20050064524A1 (en) * 2003-08-11 2005-03-24 Mordechai Deutsch Population of cells utilizable for substance detection and methods and devices using same
BRPI0506610A (pt) * 2004-02-03 2007-05-02 Chemagis Ltd montelucaste sódico amorfo, processo de preparação de montelucaste sódico amorfo, composição farmacêutica, método de tratamento utilizando a administração de montelucaste sódico amorfo, co-precipitado amorfo de montelucaste sódico e processo de preparação de co-precipitado amorfo de montelucaste sódico
US7403647B2 (en) * 2004-09-13 2008-07-22 Seng Enterprises Ltd. Method for identifying an image of a well in an image of a well-bearing component
EP1763665A1 (de) * 2004-07-07 2007-03-21 Seng Enterprises Limited Verfahren und vorrichtung zur identifizierung eines vertiefungsbildes auf einem bild einer komponente mit vertiefungen
WO2006021959A2 (en) * 2004-08-25 2006-03-02 Seng Enterprises Ltd. Method and device for isolating cells
EP1866075B1 (de) 2005-01-25 2010-09-08 Seng Enterprises Limited Mikrofluidische vorrichtung zur untersuchung zellen
DE102005034043B4 (de) * 2005-07-18 2019-12-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch
US20070141555A1 (en) * 2005-10-11 2007-06-21 Mordechai Deutsch Current damper for the study of cells
WO2007052245A1 (en) 2005-11-03 2007-05-10 Seng Enterprises Ltd. Method and device for studying floating, living cells
US20060223999A1 (en) * 2006-05-10 2006-10-05 Chemagis Ltd. Process for preparing montelukast and precursors thereof
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
EP2237887A2 (de) 2007-12-26 2010-10-13 Seng Enterprises Ltd. Vorrichtung zur untersuchung von lebenden zellen
EP2407534A1 (de) 2010-07-14 2012-01-18 Neo Virnatech, S.L. Verfahren und Reagenzien zum Erhalt von transkriptionell aktiven virusähnlichen Artikeln und rekombinante Virionen
CN102258777B (zh) * 2011-06-30 2012-09-26 河南农业大学禽病研究所 用鸡胚源细胞系繁殖传染性法氏囊病毒制备灭活疫苗和联苗的方法
CN111235117B (zh) * 2020-02-13 2021-08-27 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一株自然适应体外细胞培养的鸡传染性法氏囊病病毒经典株及其应用
TWI862969B (zh) * 2022-08-23 2024-11-21 財團法人紡織產業綜合研究所 液態色母組合物及彩色纖維的製備方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts

Also Published As

Publication number Publication date
JP4675447B2 (ja) 2011-04-20
CA2298956A1 (en) 2000-09-05
JP2000312593A (ja) 2000-11-14
EP1035203B1 (de) 2004-05-06
US6569422B1 (en) 2003-05-27
BR0001011B1 (pt) 2011-05-17
EP1035203A1 (de) 2000-09-13
KR100709077B1 (ko) 2007-04-19
ATE266097T1 (de) 2004-05-15
DE60010358T2 (de) 2004-09-23
US6492148B1 (en) 2002-12-10
BR0001011A (pt) 2001-07-03
PL338773A1 (en) 2000-09-11
DE60010358D1 (de) 2004-06-09
CA2298956C (en) 2009-12-01
HU226254B1 (en) 2008-07-28
ZA200001069B (en) 2000-10-20
JP2011036255A (ja) 2011-02-24
HU0000992D0 (en) 2000-05-28
HUP0000992A3 (en) 2005-06-28
KR20010069175A (ko) 2001-07-23
PT1035203E (pt) 2004-08-31
ES2220333T3 (es) 2004-12-16
HUP0000992A2 (hu) 2000-11-28
PL198981B1 (pl) 2008-08-29

Similar Documents

Publication Publication Date Title
DK1035203T3 (da) Cellekultur-tilpassede, genetisk manipulerede mutanter af infektiös bursalsyge-virus (IBDV)
Pilipenko et al. Prokaryotic-like cis elements in the cap-independent internal initiation of translation on picornavirus RNA
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
EP1394259A3 (de) Rekombinantes infektiöses nicht-in-Segmente-geteiltes negativ-Strange-RNS-Virus
AU1138388A (en) Hybrid rna virus
YU37502A (sh) Infektivni klonovi
NO874750L (no) Bestemte dna-sekvenser avledet fra et papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater.
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
NO2011024I1 (no) Laksepankreassykdomsvirus (SPDV) stamme F93-125; deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen
CA2186044A1 (en) Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
PL373992A1 (en) Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
IL164523A0 (en) Cytokine receptor
BR0012433A (pt) Vìrus recombinante, infeccioso de doença bursal infecciosa, método para obter o mesmo, ibdv mosaico infeccioso (mibdv), e, vacina
MXPA01005808A (es) Cepa de virus de enfermedad bursal infecciosa para administracion en huevo.
AU2002212555A1 (en) Yeast derived vaccine against ipnv
WO2002088338A3 (fr) Procede de replication du virus de l'hepatite c
DE69125066D1 (de) cDNS-Sequenz und Detektion des Hepatitis C-Virus
Palukaitis et al. Variation in the hypervariable region of cucumber mosaic virus satellite RNAs is affected by the helper virusand the initial sequence context
DE69934329D1 (de) Verfahren zur genetischen veränderung einer viralen wildtyp-sequenz
ATE389726T1 (de) Infektiöse vektoren und pflanzenklone, die sich von turnip mosaikvirus herleiten
WO1994004565A3 (en) Ipnv vaccine
WO2001011065A3 (en) Hepatitis a virus clones adapted for growth in agmk cells
CA2351010A1 (en) A broad spectrum infectious bursal disease virus vaccine
WO2000055301A3 (en) Method for inducing viral resistance into a plant
WO2000005347A3 (en) Hepatitis b culture system